INO-3107 shows promise in reducing surgeries for RRP patients
PLYMOUTH MEETING, Pa. - INOVIO (NASDAQ: INO), a biotechnology company with a market capitalization of approximately $69 million, has announced positive results from a Phase 1/2 clinical trial of ...
Inovio announces peer-reviewed data from phase 1/2 clinical trial with INO-307
Inovio (INO) announced that peer-reviewed data from its Phase 1/2 clinical trial with INO-3107 as a potential treatment for recurrent ...
Hosted on MSN1mon
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally
a gene therapy being investigated as a treatment option for adult patients with recurrent respiratory papillomatosis (RRP). RRP is a rare condition when benign tumors called papillomas grow in the ...
WebMD5y
Vitamins by Condition
Considering taking supplements to treat recurrent respiratory papillomatosis? Below is a list of common natural remedies used to treat or reduce the symptoms of recurrent respiratory papillomatosis.